MHRA reminds prescribers of latest advice regarding adrenaline auto-injectors

In an effort to support safe use of adrenaline auto-injectors the MHRA has published a summary of all relevant alerts and letters issued to healthcare professionals in recent months.

Patients should continue to follow existing advice to carry two in-date pens with them at all times. | SCIENCE PHOTO LIBRARY

The latest issue of the Drug Safety Update provides an overview of recent advice relating to Emerade, EpiPen and Jext, the three adrenaline auto-injector devices available in the UK.

The advice for healthcare professionals covers possible activation failure with Emerade pens, including what to tell patients and/or carers in possession of these devices. Images showing what the pen should look like before and after activation are included in a recent letter to patients.

The update reiterates that any suspected product quality defects should be reported to the Yellow Card Scheme. Devices that are thought to be non-activated or otherwise defective should be retained for investigation and the manufacturer contacted for advice.

The update also recaps the information sent to healthcare professionals regarding the extended use of specific batches of EpiPen and Jext beyond their labelled expiry dates, an action which was taken to support adequate supply of these products.

MHRA advice for patients applicable to the use of all three adrenaline auto-injectors was issued in August 2018 and remains valid.

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in

More from MIMS

Pregnant woman having an ultrasound scan with a female sonographer

Valproate prescribing: plan for new regulatory measures without delay, instructs MHRA

A National Patient Safety Alert (NatPSA) has been issued...

Products coming soon - live tracker

EXCLUSIVE TO SUBSCRIBERS Monitor forthcoming UK drug...

New and deleted indications - live tracker

EXCLUSIVE TO SUBSCRIBERS See the latest changes to...

Drug shortages - live tracker

EXCLUSIVE TO SUBSCRIBERS Use our constantly updated...